AI Improves prostate cancer (PCa) detection: Clinical Validation of AI models
ProCAncer-I results | Prof. Daniele Regge on clinical validation In this video, we present the results of the clinical validation of AI models that were developed during the ProCAncer-i Project. Clinical validation is a critical step to ensure that AI tools not only...
Εstablishing robust AI Models for prostate cancer (PCa) care through data-driven decision support
ProCAncer-I results | Prof. Papanikolaou on Prostanet including PI-QUAL Study and tools Since its inception, the ProCAncer-I project has aimed to establish a robust, ethically compliant AI platform—ProstateNet—to revolutionize prostate cancer (PCa) care through...
Podcast Spotlight: How ProCAncer-I is paving the way for data-driven, patient-centric prostate cancer care with AI tools
In the following AI-generated audio file, ProCAncer-I achievements are described in a simple way. Since its inception, the ProCAncer-I project has been on a mission to transform prostate cancer (PCa) care through advanced AI and ethically compliant data platforms. At...
Podcast Spotlight: The Future of Trustworthy AI in Healthcare
The role of artificial intelligence (AI) in healthcare is expanding rapidly, but trust remains a crucial barrier to its widespread adoption. The following AI-generated audio file, titled, serves as an example of how AI-driven technologies can contribute to medical research and education.
Dissemination Event of the ProCAncer-I Project in Vienna, Austria
ProCAncer-I organised the 4th Dissemination Event of the project at the ECR 2025 held in Vienna, Austria, February 25-26, 2025. During the congress, ProCAncer-I organised a Dedicated Session on the project on the 26th of February 2025, at 15.00-16.00, with the title...
The brand effect: how different MRI machines trip up AI
Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...
Dissemination Event of the ProCAncer-I Project in Vienna
We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025. Date: 26 February 2025 Time: 15:00 – 16:00 Location: ECR 2025, Vienna, Austria (conference...
ProCAncer-I at the ECR 2025 in Vienna
ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...
ProCAncer-I at the Healthcare Business Awards 2024
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces
ProCAncer-I at the first EIT Health Morning Talks in Bosnia and Herzegovina
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces
ProCAncer-I at the EMUC24 in Lisbon
The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices were discussed at the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24). The congress took place from the 7th to 10th of November 2024...
Third Dissemination Event of the ProCAncer-I Project in Athens
ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...